English
|
Spanish
Login
Register
The content on this site is intended for healthcare professionals only
For the latest
e
cancer COVID-19 resources, click on this link
Home
News
Journal
Video
e
learning
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
e
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Login
Videos
[1699]
News
[2676]
Articles
[104]
Editorials
[3]
Conferences
[86]
e
learning
[4]
Monoclonal antibody-based quadruplet therapy, AHCT and MRD response-adapted cons...
Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA
12 Dec 2021
Latest in combination therapy for NDMM patients
Prof Luciano Costa - University of Alabama at Birmingham, Birmingham, USA
12 Dec 2021
Lenalidomide and rituximab as front-line chemo-free therapy for elderly frail pa...
Dr Guido Gini - Università Politecnica delle Marche, Ancona, Italy
11 Dec 2021
Antibody and T-cell responses to COVID-19 vaccination in myeloproliferative neop...
Dr Chi-Joan How - Brigham and Women's Hospital, Boston, USA
11 Dec 2021
Allogeneic CAR-T PBCAR0191 with intensified lymphodepletion is highly active in ...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
11 Dec 2021
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
Prof Ryan Lynch - University of Washington School of Medicine, Seattle, USA
11 Dec 2021
ZUMA-12: A phase 2 study of axi-cel as first-line therapy in patients with high-...
Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston...
11 Dec 2021
Potentially targetable pathways ID’d for augmenting CAR-T cell therapy for DLBCL
Prof Brian Hill - Cleveland Clinic, Cleveland, USA
11 Dec 2021
Mosunetuzumab induces deep and durable remissions in 3L R/R follicular lymphoma
Prof Elizabeth Budde - City of Hope, Duarte, USA
11 Dec 2021
Study indicates circulating tumour cell assessment should be part of multiple my...
Dr Juan-José Garcés - Clinica Universidad de Navarra, Pamplona, Spain
11 Dec 2021
Initial treatment options for relapsed/refractory multiple myeloma patients
Dr Maria-Victoria Mateos - University Hospital of Salamanca-IBSAL, Salamanca, Sp...
11 Dec 2021
ZUMA-5 update: Axicabtagene ciloleucel continues to show strong effect in R/R iN...
Prof Sattva Neelapu - The University of Texas MD Anderson Cancer Center, Houston...
11 Dec 2021
<
1
2
3
4
5
...
142
>
More from
e
cancer